In October 2024, as reported by Japanese media, a research team headed by Katsu Takahashi at Kyoto University Hospital launched a phase I clinical trial of "TRG035", the world's pioneering tooth regeneratio... Read More
Recently, RiboX Therapeutics Ltd., based in Princeton, New Jersey, has received a significant boost with the approval of the Investigational New Drug (IND) application for its RXRG001 by the US Food... Read More